Selvita S.A. Logo

Selvita S.A.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Selvita S.A. is one of Europe's largest preclinical Contract Research Organizations (CROs), providing integrated services for the pharmaceutical, biopharmaceutical, and chemical industries. The company specializes in drug discovery and development, with a mission to bridge the gap between early discovery and the clinical stages. Selvita offers a comprehensive scope of solutions, including high-quality research and development support and advanced analytical services. It supports client projects across various therapeutic areas, helping to accelerate the development of new therapies for patients.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Selvita S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 17:13
Registration Form
Tekst jednolity statutu Selvita S.A._ENG
English 234.8 KB
2025-08-26 17:13
Registration Form
Tekst jednolity statutu Selvita S.A._PL
Polish 235.0 KB
2025-08-26 17:13
Registration Form
Rejestracja zmian Statutu Spółki / Registration of Articles of Association Amen…
Polish 1.7 KB
2025-07-22 17:17
Regulatory News Service
Otrzymanie istotnych zleceń przez spółkę zależną Selvita S.A. / Receipt of a si…
English 2.2 KB
2025-07-22 17:17
Regulatory News Service
Otrzymanie istotnych zleceń przez spółkę zależną Selvita S.A. / Receipt of a si…
Polish 1.7 KB
2025-06-30 20:46
Board/Management Information
Powołanie Członków Zarządu Selvita S.A. na kolejną kadencję / Appointment of th…
English 9.2 KB
2025-06-30 20:46
Board/Management Information
Powołanie Członków Zarządu Selvita S.A. na kolejną kadencję / Appointment of th…
Polish 9.5 KB
2025-06-30 16:02
Board/Management Information
Powołanie Członków Rady Nadzorczej Selvita S.A. na kolejną kadencję. / Appointm…
English 8.5 KB
2025-06-30 16:02
Post-Annual General Meeting Information
Powołanie Członków Rady Nadzorczej Selvita S.A. na kolejną kadencję. / Appointm…
Polish 8.8 KB
2025-06-30 16:00
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 2.0 KB
2025-06-30 15:58
Post-Annual General Meeting Information
Resolutions
English 291.0 KB
2025-06-30 15:58
Post-Annual General Meeting Information
Uchwały
Polish 202.2 KB
2025-06-30 15:58
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie Selvita S.A. / Resolu…
Polish 746 bytes
2025-06-26 21:21
Regulatory News Service
Otrzymanie istotnego zlecenia przez spółkę zależną Selvita S.A. - Content (PL)
Polish 2.4 KB
2025-06-24 21:17
Regulatory News Service
Otrzymanie istotnego zlecenia przez spółkę zależną Selvita S.A. - Content (PL)
Polish 1.6 KB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN